'Extraordinary' new cancer drug appears to cure a third of terminal patients

'Extraordinary' new cancer drug appears to cure a third of terminal patients

A private drug company has developed an experimental cancer drug that has produced apparently "extraordinary" results, with a third of very ill lymphoma patients showing no signs of the disease after a single treatment. However the company, Kite Pharma, cautioned that its version of CAT-T cell therapy may have also killed two of the 101 people in the study.

co.uk